BVF Inc’s Vigil Neuroscience VIGL Stock Holding History

BVF Inc’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,013,633	Closed	-$7.14M	–	52
2025 Q1	$7.14M	Buy	4,013,633 +2,200,000	+121%	+$4.94M	0.29%	37
2024 Q4	$3.08M	Hold	1,813,633	–	–	0.1%	47
2024 Q3	$6.17M	Hold	1,813,633	–	–	0.18%	40
2024 Q2	$7.25M	Hold	1,813,633	–	–	0.2%	40
2024 Q1	$6.18M	Hold	1,813,633	–	–	0.17%	45
2023 Q4	$6.13M	Hold	1,813,633	–	–	0.15%	53
2023 Q3	$9.78M	Hold	1,813,633	–	–	0.26%	46
2023 Q2	$17M	Hold	1,813,633	–	–	0.48%	37
2023 Q1	$17.8M	Hold	1,813,633	–	–	0.65%	41
2022 Q4	$22.7M	Hold	1,813,633	–	–	0.96%	33
2022 Q3	$16.5M	Buy	+1,813,633	New	+$13.3M	0.68%	44

Other funds holding VIGL

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return